• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kinetics of macromolecules injected into the subretinal space.

作者信息

Marmor M F, Negi A, Maurice D M

出版信息

Exp Eye Res. 1985 May;40(5):687-96. doi: 10.1016/0014-4835(85)90138-1.

DOI:10.1016/0014-4835(85)90138-1
PMID:2408910
Abstract

Small, experimental, non-rhegmatogenous retinal detachments (blebs) in rabbit eyes resorbed 50% more slowly when filled with autologous serum than with Hanks' solution. To study the fate of large molecules in the subretinal space, carboxyfluorescein and several sizes of FITC-dextrans were injected into blebs and their movement followed by fluorophotometry. Carboxyfluorescein diffused quickly into the vitreous and was gone from the space after 8 hr. FITC-dextran 10-S (smaller than albumin) also diffused readily into the vitreous and took about 30 hr to be eliminated from the subretinal space. The diffusion of FITC-dextran 70-S and 150-S (both larger than albumin) was markedly slower, and roughly 80% of the 150-S was still present in the subretinal space after 3 days. Since the subretinal fluid in all of these blebs resorbed within 10 hr, the physiologic mechanisms for fluid resorption and elimination of large substances appear to be independent. Damaging the RPE barrier with sodium iodate allowed even the larger FITC-dextrans to exit from the subretinal space.

摘要

相似文献

1
Kinetics of macromolecules injected into the subretinal space.
Exp Eye Res. 1985 May;40(5):687-96. doi: 10.1016/0014-4835(85)90138-1.
2
The rate and source of albumin entry into saline-filled experimental retinal detachments.白蛋白进入充满生理盐水的实验性视网膜脱离的速率及来源。
Invest Ophthalmol Vis Sci. 1994 Oct;35(11):3792-8.
3
Albumin movement out of the subretinal space after experimental retinal detachment.实验性视网膜脱离后白蛋白从视网膜下间隙的移动。
Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1298-305.
4
The resorption of subretinal fluid after diffuse damage to the retinal pigment epithelium.视网膜色素上皮弥漫性损伤后视网膜下液的吸收
Invest Ophthalmol Vis Sci. 1983 Nov;24(11):1475-9.
5
When vitreous enters the subretinal space. Implications for subretinal fluid protein.当玻璃体进入视网膜下间隙时。对视网膜下液蛋白质的影响。
Retina. 1996;16(5):426-30. doi: 10.1097/00006982-199616050-00010.
6
Mechanisms of subretinal fluid resorption in the cat eye.
Invest Ophthalmol Vis Sci. 1986 Nov;27(11):1560-3.
7
Barriers to fluorescein and protein movement.荧光素和蛋白质移动的屏障。
Jpn J Ophthalmol. 1985;29(2):131-8.
8
Healing of photocoagulation lesions affects the rate of subretinal fluid resorption.
Ophthalmology. 1984 Dec;91(12):1678-83. doi: 10.1016/s0161-6420(84)34084-2.
9
Quantitative estimation of metabolic transport of subretinal fluid.
Invest Ophthalmol Vis Sci. 1986 Nov;27(11):1564-8.
10
Effects of subretinal and systemic osmolality on the rate of subretinal fluid resorption.视网膜下和全身渗透压对视网膜下液吸收速率的影响。
Invest Ophthalmol Vis Sci. 1984 May;25(5):616-20.

引用本文的文献

1
Mechanisms of macular edema.黄斑水肿的机制。
Front Med (Lausanne). 2023 Mar 7;10:1128811. doi: 10.3389/fmed.2023.1128811. eCollection 2023.
2
Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update.基于纳米技术的眼部疾病诊断和治疗的最新进展,综述与更新。
J Nanobiotechnology. 2022 Aug 2;20(1):361. doi: 10.1186/s12951-022-01567-7.
3
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations.眼部后段给药:生物药剂学和药代动力学考量
Pharmaceutics. 2020 Mar 16;12(3):269. doi: 10.3390/pharmaceutics12030269.
4
Noble Metals and Soft Bio-Inspired Nanoparticles in Retinal Diseases Treatment: A Perspective.贵金属和软生物启发型纳米粒子在视网膜疾病治疗中的应用:一种观点。
Cells. 2020 Mar 10;9(3):679. doi: 10.3390/cells9030679.
5
Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems.利用纳米技术和基于纳米医学的系统治疗青光眼的有前途的方法。
Molecules. 2019 Oct 22;24(20):3805. doi: 10.3390/molecules24203805.
6
Nanotechnology-based strategies for treatment of ocular disease.基于纳米技术的眼部疾病治疗策略。
Acta Pharm Sin B. 2017 May;7(3):281-291. doi: 10.1016/j.apsb.2016.09.001. Epub 2016 Nov 18.
7
Efficacy of Antibody Delivery to the Retina and Optic Nerve by Topical Administration.局部给药将抗体递送至视网膜和视神经的疗效。
J Ocul Pharmacol Ther. 2016 May;32(4):203-10. doi: 10.1089/jop.2015.0111. Epub 2016 Jan 15.
8
Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration.玻璃体内注射膨胀性气体联合贝伐单抗治疗新生血管性年龄相关性黄斑变性所致黄斑下出血
J Ophthalmic Vis Res. 2010 Jul;5(3):168-74.
9
The outer limiting membrane (OLM) revisited: clinical implications.重新审视外限制膜(OLM):临床意义。
Clin Ophthalmol. 2010 Apr 26;4:183-95. doi: 10.2147/opth.s5901.
10
FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye.FcRn受体介导的治疗性IgG在眼部的药代动力学
Mol Vis. 2009 Dec 16;15:2803-12.